Myostatin is a negative regulator of muscle mass that may contribute to the muscle wasting observed in response to traumatic injury. The purpose of this study was to determine whether muscle myostatin mRNA abundance was altered by different traumatic insults and whether the change in myostatin was associated with alterations in insulin-like growth factor (IGF)-I and IGF-II mRNA in gastrocnemius, or the concentration of glucocorticoids in plasma. The abundance of myostatin mRNA was increased three-to fourfold in gastrocnemius 24 h after a 30% total body surface area burn injury. In contrast, neither the injection of endotoxin nor the induction of peritonitis significantly altered myostatin mRNA at the same time point. IGF-I mRNA in muscle was decreased (40-60%) by all insults, whereas the abundance of IGF-II mRNA was unaltered. The plasma concentration of corticosterone was increased approximately threefold after burn injury, was only transiently elevated after endotoxin, and was only mildly increased (25%) in septic rats at the time of sacrifice. Pretreatment with the type II glucocorticoid receptor antagonist RU486 prevented the increased myostatin mRNA and decreased muscle protein content after burn. A single injection of dexamethasone in naive control animals increased muscle myostatin mRNA by 60% and 2.7-fold at 4 h and 24 h, respectively. In contrast, pretreatment of burn rats with tumor necrosis factor binding protein (TNF BP ), which antagonizes the actions of this cytokine, failed to prevent the burn-induced increase in myostatin mRNA or the loss of muscle protein. The results of this study indicate that thermal injury, but not endotoxin or sepsis, increases myostatin mRNA content. Moreover, the burn-induced increase in myostatin appears to be largely mediated by the enhanced endogenous secretion of glucocorticoids and independent of changes in IGF-I, IGF-II, or TNF.
experimental deletion of the myostatin or growth/differentiation factor-8 (GDF-8) gene in mice markedly increase skeletal muscle mass, resulting in both hyperplasia and hypertrophy (2, 4) , which emphasizes the role of this protein as a negative regulator of muscle mass. On the basis of this evidence, it is clear that the lack of myostatin during embryonic development has profound effects on the proliferation and differentiation of skeletal muscle. However, the role played by this factor in modulating muscle mass in adult animals is less clear.
One of the hallmarks of various types of catabolic illness is the negative nitrogen balance and the erosion of lean body mass (5) . In general, this muscle wasting results from decreases in muscle protein synthesis and/or increases in muscle proteolysis (6, 7) . Investigations into the underlying mechanism responsible for this myopathy suggest a putative role for the enhanced synthesis and secretion of various inflammatory cytokines and glucocorticoids (6, 7) . However, the potential significance of changes in myostatin in regulating muscle mass in response to catabolic insults is largely unexplored. Previous studies have demonstrated an inverse correlation between myostatin-immunoreactive protein in serum and muscle, and lean body mass in HIV-infected patients with weight loss (8) . Similarly, gastrocnemius myostatin mRNA was also increased, albeit transiently, in response to atrophy produced by hind-limb unloading (9) . However, the increase in myostatin does not appear to be acutely regulated by a reduction in energy availability per se (9, 10) . The potential importance of myostatin as a negative regulator of muscle mass is emphasized by results from a recent study that demonstrated a decreased rate of protein synthesis in C 2 C 12 myocytes cultured in the presence of human recombinant myostatin (11) .
In contrast to myostatin, insulin-like growth factor-I (IGF-I) and IGF-II are structurally related peptides that positively regulate proliferation and differentiation of skeletal muscle (12) . Exogenous administration of IGF-I to adult animals both stimulates protein synthesis (13) and inhibits proteolysis (14) . We have previously demonstrated a marked decrease in muscle IGF-I mRNA and peptide content in response to various catabolic insults, including thermal injury, sepsis, and endotoxemia (6, 15, 16) . Moreover, this decrease in IGF-I appears to result largely from elevations in proinflammatory cytokines and/or glucocorticoids (6, 16, 17) . There is also evidence linking the IGF system with members of the TGF-β family. In this regard, the addition of IGF-I to myoblasts produces a dose-dependent decrease in the steady-state expression of TGF-β1 and -β3 mRNA (18) . In addition, during muscle regeneration, the lack of myostatin is associated with an increase in IGF-II mRNA expression (19) . Similarly, a significant inverse relationship between muscle levels of myostatin and IGF-II was also observed in response to muscle atrophy induced by weightlessness (20) . The purpose of this study was to test the hypothesis that the catabolic state induced by burn injury, sepsis, or endotoxemia is associated with an increase in muscle myostatin mRNA and a concomitant reduction in muscle IGF-I or IGF-II mRNA. Furthermore, the role of endogenous glucocorticoids and tumor necrosis factor (TNF)α in mediating the burn-induced changes in myostatin mRNA expression was also assessed by treating rats with selective antagonists to these catabolic factors.
MATERIALS AND METHODS

Animal preparation and experimental protocol
Adult specific pathogen-free male Sprague-Dawley rats (Charles River Breeding Laboratories, Cambridge, MA; 250-300 g) were housed at a constant temperature, exposed to a 12:12-h lightdark cycle, and maintained on standard rodent chow and water ad libitum for at least 1 wk before experiments were performed. All experiments were approved by the Animal Care and Use Committee at the Pennsylvania State University College of Medicine and adhered to the National Institutes of Health guidelines for the use of experimental animals.
In the first experimental series, three different types of traumatic injury were induced in separate groups of rats. Thermal injury was induced as previously described (15) . In brief, all rats were deeply anesthetized with an intraperitoneal injection of ketamine and xylazine (100 and 10 mg/kg, respectively). The hair on the dorsal and ventral surfaces of the animal was closely clipped, and animals were secured in an insulated template that exposed only the area of skin to be injured. For the burn group, the surface of the skin exposed through the template was immersed in 98°C water for 12 s on the dorsal surface and 7 s on the ventral surface. This technique produces a full-thickness scald injury with complete destruction of the underlying neural tissue. For this study, the scald injury covered ∼30% of the total body surface area (TBSA). Rats were dried and resuscitated by an intraperitoneal injection of lactated Ringer's solution (2 ml/kg/% TBSA burn). Sham-burn control rats were treated identically to those in the burn group, except that they were immersed in 25°C water. All rats were injected subcutaneously with the analgesic buprenorphine (0.2 mg/kg) immediately after sham or burn injury. Rats were returned to individual cages and fasted for the remainder of the experimental protocol. Blood and tissues were sampled ∼24 h after injury. This time point was selected based on previous studies demonstrating an impairment of muscle protein synthesis or degradation (21) and alterations in the various components of the IGF system (15) . Rats were decapitated, and trunk blood was collected into heparinized syringes. Selected tissues were then rapidly excised and frozen between aluminum blocks precooled to the temperature of liquid nitrogen. All tissue and plasma samples were stored at ∼70°C until analyzed.
A separate group of male Sprague-Dawley rats was injected with a nonlethal dose of endotoxin (Escherichia coli 026:B6, 100 µg/100 g body weight; LD 0 at 24 h; Difco, Detroit, MI). Rats were lightly wrapped in a porous towel, and endotoxin or an equal volume of saline (0.5 ml/100 g body weight) was injected by percutaneous puncture of a lateral tail vein. All animals were fasted after treatment, and blood and tissues were collected at either 4 h or 24 h post-endotoxin administration. The hemodynamic and metabolic sequella of this dose of endotoxin have been previously described (16, 22) . In a separate group of rats, peritonitis was induced by the implantation of a sterilized fecal-agar pellet inoculated with E. coli and Bacteroides fragilis into the peritoneal cavity, as previously described (6) . Control animals had a midline laparotomy performed and a sterile agar pellet implanted. Both control and septic rats were fasted after surgery and sacrificed 24 h later. Blood and muscle were collected as described previously.
Based on data from the previously mentioned experiments, additional studies were performed to determine the role of glucocorticoids in modulating burn-induced changes in myostatin. Control and burn rats were injected subcutaneously with either saline or the glucocorticoid receptor antagonist RU486 (20 mg/kg, Mifepristone; Sigma, St. Louis, MO) 30 min before burn or sham injury. RU486 is an antiprogestin, which has a high affinity for cytosolic type II glucocorticoid receptors in various target tissues and exhibits little agonist activity (23) . The dose of RU486 used in this study is known to attenuate the glucocorticoid-induced increase in muscle catabolism as well as to prevent or attenuate endotoxin-or cytokine-induced changes in the IGF system (7, 16, 24) . To determine the potential role of endogenously produced TNFα, separate groups of burn and control rats were injected subcutaneously with TNF binding protein (TNF BP ; 1mg/kg, 1 ml/rat; Amgen, Boulder, CO), which antagonizes the actions of TNF, 4 h before thermal injury. TNF BP is a dimeric, polyethylene glycol-linked form of the human p55 soluble TNF receptor (25) . The timing and dose of the synthetic TNF antagonist are based on previous work demonstrating its ability to prevent the sepsis-induced loss of muscle mass (26) and the burninduced changes in the IGF system (Lang and Frost, unpublished observations).
To determine whether an elevation in the plasma glucocorticoid concentration could alter myostatin expression in control animals, a separate group of rats was injected subcutaneously with dexamethasone (100 µg/100 g body weight; Sigma) or with an equal volume (0.5 ml/rat) of vehicle. This dose of dexamethasone is known to decrease muscle protein synthesis and impair peptide-chain initiation (27) . Rats were fasted overnight, and blood and muscle were collected at either 4 h or 24 h after injection of dexamethasone. The ability of RU486 (20 mg/kg) to prevent the dexamethasone-induced increase in myostatin mRNA was also addressed.
Analytical methods
Total RNA from whole tissues (liver, kidney, gastrocnemius, soleus, psoas, and heart) frozen with liquid nitrogen was isolated using TRI reagent TR-118 (Molecular Research Center, Cincinnati, OH). The RNA pellets were resuspended and stored in formamide at -20°C. RNA quantity and purity were determined by measuring absorbance at 260 nm and 280 nm. RNA from each tissue (20-30 µg) was separated on a 1.1% agarose/6% formaldehyde gel under denaturing conditions. After electrophoresis, the separated RNA was transferred to a Nytran Supercharge membrane (Schleicher and Schuell, Keene, NH) for Northern blotting. A 325-bp probe from rat IGF-I (Peter Rotwein, Portland, OR) and a 551-bp probe from rat IGF-II (Harvey Whitfield, Chicago, IL) were labeled using a Random Primed DNA Labeling kit (Roche Molecular Biochemicals, Indianapolis, IN). To determine myostatin mRNA content, a 36mer oligonucleotide was created at the Penn State College of Medicine Macromolecular Core Facility by using the sequence 5'CAGCCCATCTTCTCCTGGTCCTGGGAAGGTTACAGC3'. The oligonucleotide was radioactively end labeled using T4 polynucleotide kinase (Promega, Madison, WI). To normalize for RNA loading, a rat 18S oligonucleotide was also radioactively end labeled using T4 polynucleotide kinase. Membranes were prehybridized and hybridized in Ultrahyb (Ambion, Austin, TX) at 42°C. All membranes were washed at 42°C two times in 2× standard sodium citrate (SSC)/0.1% sodium dodecyl sulfate (SDS) for 5 min and one time in 0.2× SSC/0.1% SDS for 15 min. Membranes hybridized with myostatin were further washed at 50°C for 20 min in 0.2× SSC/0.1% SDS. Membranes were exposed to a phosphoimager screen. After the exposure period, the screen was scanned using a Phosphoimager (Molecular Dynamics, Sunnyvale, CA) and the resultant data were quantified using ImageQuant software (Molecular Dynamics).
Plasma TNFα concentrations were determined using a rat-specific ELISA (Biosource, Camarillo, CA). The lower limit of detection for this assay is ∼15 pg/ml. Muscle protein content was calculated as the product of muscle weight (g) and the muscle protein concentration (mg protein/g dry weight of muscle). The dry weight of muscle was determined by weighing muscle before and 48 h after drying at 110°C.
Statistics
Results are expressed as means ± SE. The exact number of animals per group is indicated in the figure and table legends. For each study, rats were randomly assigned to either the experimental group or the control group. For experiments with two groups, data were analyzed by the unpaired t test; for experiments with three or more groups, data were analyzed by analysis of variance followed by Student-Newman-Keuls to determine treatment effect. All data approximated a normal distribution, and when heterogeneity of variance was detected, data were first transformed to logarithmic values (Instat, San Diego, CA). Statistical significance was set at P < 0.05.
RESULTS
Effect of burn, endotoxin, or sepsis on myostatin
Twenty-four hours after thermal injury, myostatin mRNA abundance was increased more than threefold in the gastrocnemius (Fig. 1, top panel) . A similar burn-induced increase in myostatin mRNA was detected in psoas muscle (control=1.0 ±0.2 AU vs. burn=4.6 0.8 AU; P<0.05). In contrast, the injection of endotoxin or the induction of sepsis did not significantly alter myostatin mRNA in gastrocnemius, compared with appropriate time-matched control animals (Fig. 1 , middle and bottom panels). Using Northern blot analysis, we did not detect myostatin mRNA in soleus, heart, liver, or kidney in either control or burned rats (data not shown). Twenty-four hours after injury, the decrease in muscle protein content (in mg protein/g dry weight) was comparable in response to the different traumatic insults (burn=108 ±3* vs. control=117 ±2; LPS=98 ±4* vs. control=113 ±3; and sepsis=103 ±4* vs. control=114 ±2; *P<0.05 compared with appropriate control value).
The abundance of IGF-I and IGF-II mRNA in gastrocnemius as well as the plasma concentrations of corticosterone were also determined ( Table 1) . Thermal injury decreased IGF-I mRNA by 45%. Endotoxin decreased muscle IGF-I mRNA by 58% at 4 h and 32% at 24 h. IGF-I mRNA was reduced 29% in gastrocnemius from septic rats. In contrast, none of the traumatic injuries significantly altered the steady-state levels of IGF-II mRNA in gastrocnemius. The plasma corticosterone concentration was increased after burn injury (141%), compared with control values. Corticosterone was also increased 4 h after endotoxin administration (104%), but levels had returned to control values by 24 h. A small, albeit statistically significant, 25% increase in corticosterone was detected in rats 24 h after induction of sepsis.
The second experimental series was designed to determine the role of endogenous glucocorticoids in modulating the burn-induced increase in muscle myostatin. To address this issue, rats were pretreated with the glucocorticoid receptor antagonist RU486. Figure 2 (top panel) illustrates that in this study burn increased myostatin mRNA content by ∼4-fold, and this elevation was almost completely prevented in rats administered RU486. There was no difference in myostatin mRNA in control animals injected with RU486, compared with vehicle-treated control animals. RU486 also prevented the burn-induced reduction in gastrocnemius protein content (Fig. 2, bottom panel) . Neither burn injury nor RU486 significantly altered the protein content of the soleus muscle (data not shown). On the basis of these results, we speculated that the exogenous administration of glucocorticoids to naive control animals should also be able to elevate myostatin mRNA. Figure 3 (top panel) illustrates that myostatin mRNA was increased 60% and 2.7-fold in gastrocnemius at 4 h and 24 h, respectively, after a single injection of dexamethasone. Figure 3 (bottom panel) also illustrates that pretreatment with RU486 completely prevented the dexamethasone-induced increase in myostatin, demonstrating the efficacy of the glucocorticoid antagonist. These changes in myostatin were associated with corresponding changes in muscle protein content (control=114 ±2, DEX=106 ±2*, and RU486+DEX=116 ±3 mg protein/g dry weight; *P<0.05 compared with other groups).
Several studies have demonstrated that burn injury is associated with an elevation in plasma or tissue levels of the proinflammatory cytokine TNFα (28, 29) . Furthermore, administration of TNFα to control animals stimulates loss of muscle protein (30) . TNFα was below the limit of detection (<15 pg/ml) in the blood from both control and burn rats when assayed at the 24-h time point. However, it is possible that thermal injury increased TNFα expression in muscle. Hence, additional rats were treated with TNF BP before thermal injury to antagonize the in vivo effects of this cytokine. Figure 4 illustrates that TNF BP failed to significantly prevent either the burninduced increase in myostatin mRNA in gastrocnemius or the reduction in muscle protein content.
DISCUSSION
The results of this study indicate that myostatin mRNA abundance was markedly increased in the predominately fast-twitch gastrocnemius and psoas muscles 24 h after ∼30% TBSA burn injury in adult rats. These muscles are primarily composed of fast-twitch fibers and are representative of other muscles in the body with a similar fiber-type composition. In contrast, the abundance of myostatin mRNA in the predominantly slow-twitch soleus muscle as well as that in heart, liver, and kidney was below the detection of our Northern blot analyses in both control and burn rats. This tissue specificity is consistent with previous observations made using similar methodology (3, 4, 9, 30) . However, relatively low levels of myostatin have been detected in cardiomyocytes isolated from fetal and adult sheep through the use of a more sensitive RT-PCR technique (31).
The burn-induced increase in myostatin was associated with a reduction in the protein content of the gastrocnemius muscle. Previous studies have demonstrated that the imbalance in protein metabolism 24 h after thermal injury results from both an increase in the rate of protein degradation and a reduction in muscle protein synthesis (32) . It is noteworthy that the burninduced alterations in protein metabolism are more pronounced in fast-twitch, as opposed to slow-twitch, skeletal muscle, and this differential response is consistent with the observed increase in myostatin in the gastrocnemius, but not in the soleus. Moreover, these changes in protein metabolism and myostatin occurred in a muscle distant from the site of thermal injury, suggesting the involvement of one or more neurohumoral agents. The increase in myostatin, however, did not appear to be a generalized response to catabolic stimuli. No increase in myostatin mRNA was detected 24 h after the injection of endotoxin or the induction of peritonitis. Both of these insults have been reported to produce muscle wasting that is comparable to or greater than that observed after thermal injury (6, 26, 33 , and this study).
The three catabolic insults appear to elicit a glucocorticoid response that differs in magnitude and/or duration. Studies from our laboratory and others (15, 32 , and current data) indicate that burn injury results in a rapid and sustained elevation in circulating corticosterone. The intravenous injection of endotoxin also increased plasma corticosterone concentrations to a comparable level at 4 h, but concentrations had returned to basal values by 24 h. In rats with peritonitis, the plasma corticosterone concentrations were only mildly increased at the time animals were sacrificed. Hence, these initial data suggested that a sustained large elevation in glucocorticoids might be responsible for the burn-induced increase in myostatin. This conclusion is supported by data indicating that the injection of a potent synthetic glucocorticoid impairs muscle protein balance (34) and that pretreatment with the glucocorticoid receptor-antagonist RU486 is able to completely prevent the burn-induced increase in muscle protein degradation and attenuate the loss of muscle protein (32) .
In this study, we investigated the regulatory role of glucocorticoids by first determining the myostatin response in control animals to dexamethasone. Animals so treated demonstrated an increase in gastrocnemius myostatin mRNA at 24 h, comparable to that observed in burn rats. Moreover, the ability of dexamethasone to up-regulate myostatin mRNA occurred relatively rapidly, being increased by at least 4 h postinjection. In the complementary study, RU486 administered before burn injury prevented both the increase in myostatin and the reduction in muscle protein content. Collectively, these data indicate that sustained elevations in circulating glucocorticoids are capable of increasing myostatin and that an elevation in the endogenous levels of this hormone is largely responsible for the increased myostatin observed in response to thermal injury.
Although not a universal finding, burn has been reported to increase the TNFα concentration in blood or selected tissues (28, 29) , and this cytokine appears to be an important regulator of the muscle-wasting accompanying sepsis (26) . However, in this study, we were unable to detect a burn-induced increase in plasma TNFα levels, at least at the 24-h time point. We cannot exclude the possibility that TNFα was transiently increased after burn but had returned to basal undetectable levels at 24 h. Furthermore, the TNF-antagonist TNF BP was unable to significantly prevent either the burn-induced increase in myostatin mRNA or the decrease in muscle protein content. These data suggest that the overexpression of TNFα does not play a major role in regulating myostatin during this particular traumatic condition and that the physiological regulators of muscle protein balance may differ between burn and septic rats.
IGF-I and IGF-II are critical for the normal development and maintenance of lean body mass (12) . An inverse relationship has been reported for these ligands and the abundance of myostatin in response to muscle atrophy or regeneration (19, 20) . However, in the current investigation, neither burn, endotoxin, nor sepsis significantly altered IGF-II mRNA levels in gastrocnemius. These data suggest that trauma-induced changes in IGF-II do not mediate muscle protein balance either directly or indirectly through modulation of myostatin. In contrast, all three catabolic insults produced a comparable decrease in muscle IGF-I mRNA, which is consistent with previous studies (6, 15, 16, 35) . These data support, but do not prove, the hypothesis that traumainduced changes in IGF-I may be an important regulator of muscle mass, but they fail to support a strong consistent association between changes in IGF-I and myostatin.
In summary, these data indicate that steady-state levels of myostatin mRNA can be increased in adult rats by exogenous administration of glucocorticoids and that the endogenous elevation of corticosterone is a major regulator of the increased myostatin and decreased muscle protein content observed in response to thermal injury. The increase in myostatin appears relatively specific for thermal injury and was not observed in septic or endotoxin rats, suggesting that burn may alter muscle protein balance by a mechanism different from that of infection or endotoxin. Our results do not support a regulatory role for TNFα, IGF-I, or IGF-II in the in vivo control of myostatin mRNA. Burn (top left), endotoxemia (top right), or sepsis (bottom) were induced as described in "Methods and Materials." Inset for each bar graph is a representative Northern blot. Bar graphs are densitometric analysis of myostatin mRNA abundance, expressed as arbitrary volume units (AU) determined by phosphoimaging and normalized to ribosomal 18S values. For each type of injury, determination of ribosomal 18S RNA indicated that the amount of RNA loaded was similar for each lane (data not shown). Values are means ± SE. For top, n = 6 for control and 7 for burn; for middle, n = 6 for control, 6 for 4 h LPS, and 7 for 24 h LPS; and for bottom, n = 6 for control and 6 for sepsis. *P < 0.05 compared with time-matched control animals. 
